Form 4: Apyx Medical Corp Director Acquires Stock Options Under Compensation Program

Director Stavros G. Vizirgianakis acquired 50,000 stock options in Apyx Medical Corp under the company's Director Compensation Program.

Summary

• Stavros G. Vizirgianakis, a director of Apyx Medical Corp, filed a Form 4 disclosing a transaction involving derivative securities.
• On January 15, 2025, Vizirgianakis acquired 50,000 stock options with an exercise price of $1.42.
• These options were issued under the Issuer's Director Compensation Program, as amended.
• The options vest ratably over 12 months and become fully vested and exercisable on the first anniversary of the grant date.
• Following the transaction, Vizirgianakis directly owns 50,000 derivative securities (stock options).

Sentiment

Score: 6

Explanation: The document is a routine disclosure of stock option grants, which is generally neutral. The grant itself can be seen as a positive sign of aligning director interests with shareholders, but it's not a major event.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Industry Context

Director compensation packages often include stock options to incentivize performance and align director interests with shareholder value. This is a fairly standard practice in publicly traded companies.

Comparison to Industry Standards

• Stock option grants to non-employee directors are a common practice among publicly traded companies to align their interests with shareholders.
• The vesting schedule of 12 months is also a typical arrangement.
• Comparable companies in the medical device industry, such as Stryker or Medtronic, also utilize stock options as part of their director compensation packages.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive sign, aligning director interests with company performance.
• The director benefits from the potential future value of the stock options.

Key Dates